Harpoon Therapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
May 25, 2017
Vertical
Immuno-oncology
Funding Amount
$45,000,000
Company Info
Founders
Patrick Baeuerle, PhD
Market
Cancer treatment
Location
South San Francisco, California, USA
Coinvestors
Arix Bioscience, MPM Capital, New Leaf Venture Partners, Taiho Ventures
Company Description

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.